# Bleomycin

NDC: 0409-0323
Generic name: BLEOMYCIN
Labeler / Manufacturer: Hospira, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRAPLEURAL, INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20180425

FDA application: ANDA065031

## Active ingredients

- BLEOMYCIN SULFATE: 30 [USP'U]/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0409-0323"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0409-0323
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e629ba5a-4e08-4249-9551-af6dbd98a7e4